Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17368178 | 0.89 | SMN1; SMN2 (0.59) | RAB9ASMN1; SMN2NPC1TP53 | |
| SCHEMBL5999261 | 0.87 | RAB9A (0.53) | RAB9ASMN1; SMN2 | |
| SCHEMBL10253052 | 0.87 | SMN1; SMN2 (0.65) | RAB9ASMN1; SMN2KDM4ELMNACYP1A2 | |
| SCHEMBL21533563 | 0.82 | SMN1; SMN2 (0.61) | RAB9ASMN1; SMN2NPC1TP53KDM4E | |
| SCHEMBL21533567 | 0.81 | SMN1; SMN2 (0.66) | RAB9ASMN1; SMN2NPC1TP53KDM4E | |
| SCHEMBL8271658 | 0.80 | RAB9A (0.57) | RAB9ASMN1; SMN2 | |
| SCHEMBL14903117 | 0.80 | SMN1; SMN2 (0.57) | RAB9ASMN1; SMN2NPC1TP53 | |
| SCHEMBL21533452 | 0.80 | NPC1 (0.74) | RAB9ASMN1; SMN2NPC1TP53 | |
| SCHEMBL21533571 | 0.80 | SMN1; SMN2 (0.60) | RAB9ASMN1; SMN2NPC1TP53KDM4E | |
| SCHEMBL7931685 | 0.79 | HDAC3 (0.71) | SMN1; SMN2KDM4ELMNACYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010028193-A1 | COMPOUNDS INCLUDING PIMELIC ACID DERIVATIVES AS HDAC INHIBITORS | REPLIGEN CORPORATION (US) | 2010-03-11 | — | — | WO | disclosed |